Why We Built Thalocan: The Forgotten Links in Dermatology Clinical Trials Interview with Eric Zudak, CEO of Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. There’s a moment in every startup story when frustration turns into fuel. For Eric Zudak, founder of Thalocan Research Innovations, that moment came when a global pharmaceutical company called…
DetailsAccelerating Scale Validation with TAVOS: A Game Changer for Disease Assessment Rater scales have become the standard for measuring endpoints in dermatology clinical research. These instruments are now essential tools for evaluating efficacy in inflammatory skin disease trials. Yet, the process of developing and validating scales remains anything but standard. It is labor-intensive, costly, and…
Details“Thalocan provided an excellent service for production of our rating-scale training video. They were well connected, quickly sourcing actors, studios and disease area experts; also clearly experienced in post-production work with timely delivery of a high quality, polished, final product. I found them professional, helpful and solution-focused throughout. Highly recommended.”Senior Clinical Development Director A large…
Details
